Monoamine oxidase activities in human cystic and colonic arteries — influence of age

  • I. V. Figueiredo
  • A. Martinez Coscolla
  • M. D. Cotrim
  • M. M. Caramona
  • B. A. Callingham
Part of the Journal of Neural Transmission. Supplement book series (NEURAL SUPPL, volume 52)


The deamination of 5-hydroxytryptamine, phenylethylamine and benzylamine by monoamine oxidases (MAO-A and B) and semicarbazide sensitive amine oxidase (SSAO) respectively has been studied in homogenates of human cystic and colonic arteries by radiochemical assays. In cystic artery the deamination is mainly carried out by SSAO with a lower participation of MAO-B. The kinetic parameters were: to MAO-B the Vmax = 15.11 ± 0.51nmol/mg protein.h and the Km = 78.51 ± 5.16 μM (±SE) and to SSAO the Vmax = 211.70 ± 8.75nmol/mg protein.h and the Km = 211.51 ± 23.27 μM (±SE). We could not measure MAO-A activity in our experimental conditions and also the levels of catecholamines are very low and the histological studies show a poor innervation in these tissues. In colonic artery the kinetic parameters were: to MAO-B the Vmax = 5.09 ± 0.31nmol/mg protein.h and the Km = 29.12 ± 4.55 μM (±SE) and to SSAO the Vmax = 273.67 ± 8.35nmol/mg protein.h and the Km = 197.89 ± 21.81 μM (±SE). In this artery we could find MAO-A in five among the nine samples studied and the kinetic parameters were: the Vmax = 14.48 ± 0.82nmol/mg protein.h and the Km = 136.40 ± 25.46 μM.

As we have performed the experiments with human vessels from donors with different age we could not find any relationship between the activity or affinity, in MAO-B and SSAO, with age. Nevertheless, the results show in cystic artery an increase in the affinity of MAO-B with age when we consider the female group which suggests a possible role of the hormonal condition in this behaviour.


Monoamine Oxidase Amine Oxidase Cystic Artery Oxidative Deamination Monoamine Oxidase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Banchelli G, Buffoni F, Elliott J, Callingham BA (1990) A study of the biochemical pharmacology of 3,5-ethoxy-4-aminomethylpyiridine (B24), a novel amine oxidase inhibitor with selectivity for tissue bound semicarbazide-sensitive amine oxidase enzymes. Neurochem Int 17: 215–221PubMedCrossRefGoogle Scholar
  2. Branco D, Caramona MM, Martel F, Ferreira de Almeida JA, Osswald W (1992) Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery. Naunyn Schmiedebergs Arch Pharmacol 346: 286–293PubMedCrossRefGoogle Scholar
  3. Buffoni F (1993) Properties, distribution and physiological role of semicarbazide-sensitive amine oxidase. Curr Topics Pharmacol 2: 33–50Google Scholar
  4. Cabrita AMS (1986) A imunocitoquímica no estudo das lesões neoplásicas. Arq Patol Geral Anat Patol Univ Coimbra Vol XX (Nova série): 97–104Google Scholar
  5. Callingham BA (1983) Comparative aspects of monoamine oxidase. Vet Res Commun 7: 325–330PubMedCrossRefGoogle Scholar
  6. Callingham BA (1986) Some aspects of monoamine oxidase pharmacology. Cell Biochem Funct 4: 99–108PubMedCrossRefGoogle Scholar
  7. Callingham BA, Barrand MA (1987) Some properties of semicarbazide-sensitive amine oxidases. J Neural Transm [Suppl] 23: 37–54Google Scholar
  8. Caramona MM (1982) Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Naunyn Schmiedebergs Arch Pharmacol 319: 121–124PubMedCrossRefGoogle Scholar
  9. Elliot J, Callingham BA, Sharman DF (1989) Semicarbazide-sensitive amine oxidase (SSAO) on rat aorta: interactions with some naturally occurring substrates and their structural analogues. Biochem Pharmacol 38: 1507–1515CrossRefGoogle Scholar
  10. Elliot J, Callingham BA, Sharman DF (1991) Amine oxidase enzymes of sheep blood vessels and blood plasma: a comparison of their properties. Comp Biochem Physiol 102: 83–89Google Scholar
  11. Figueiredo IV, Caramona MM, Cotrim MD, Fontes Ribeiro CA, Macedo TRA, Pereira J, Silveira L, Falcão F (1995) The activity of semicarbazide sensitive amine oxidase in human uterine arteries. Pharmacol Res 31 [Suppl]: 240CrossRefGoogle Scholar
  12. Fowler CJ, Callingham BA (1978) Monoamine oxidase A and B: a useful concept? Biochem Pharmacol 27: 97–101CrossRefGoogle Scholar
  13. Hall DWR, Logan BW, Parsons GH (1969) Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem Pharmacol 18: 1447–1454PubMedCrossRefGoogle Scholar
  14. Johnston (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 1285–1297PubMedCrossRefGoogle Scholar
  15. Kopin IJ (1985) Catecholamines metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364PubMedGoogle Scholar
  16. Lewinshon R (1984) Mammaliam monoamine-oxidising enzymes, with special references to benzylamine oxidase in human tissues. Braz J Med Biol Res 17: 223–256Google Scholar
  17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275PubMedGoogle Scholar
  18. Lyles GA, Fitzpatrick CMS (1985) An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 37: 29–335CrossRefGoogle Scholar
  19. Osswald W (1988) Disposition of catecholamines blood vessel wall. In: Bevan JA, Majewski H, Maxwell RA, Story DF (eds) Vascular neuroeffector mechanisms. IRL Press, Oxford, pp 321–329Google Scholar
  20. Osswald W, Guimaraes S (1983) Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev Physiol Biochem Pharmacol 96: 53–122PubMedCrossRefGoogle Scholar
  21. Rode J, Dhillon AP (1984) Neuron specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopath 8: 1041–1052CrossRefGoogle Scholar
  22. Schurr A (1982) Monoamine oxidase: to B or not to B? Life Sci 30: 1059–1063PubMedCrossRefGoogle Scholar
  23. Warnhoff M (1984) Simultaneous determination of Ne, dopamine, 5-HT and their main metabolits in rat brain using “HPLC-EC”. J Chrom 307: 271–281CrossRefGoogle Scholar
  24. Wilkinson GN (1961) Statistical estimations in enzyme kinetic. Biocem J 80: 324–332Google Scholar
  25. Yang HYT, Neff NH (1973) ß-phenylethylamine, a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187: 365–371PubMedGoogle Scholar
  26. Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Catecholamines, vol I. Springer, Berlin Heidelberg New York Tokyo, pp 119–192CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • I. V. Figueiredo
    • 1
    • 1
  • A. Martinez Coscolla
    • 2
  • M. D. Cotrim
    • 1
  • M. M. Caramona
    • 1
  • B. A. Callingham
    • 2
  1. 1.Laboratório de Farmacologia Faculdade de Farmácia daUniversidade de CoimbraCoimbraPortugal
  2. 2.Department of PharmacologyCambridge UniversityUK

Personalised recommendations